BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22906841)

  • 1. Challenges to effective cancer nanotheranostics.
    Melancon MP; Stafford RJ; Li C
    J Control Release; 2012 Dec; 164(2):177-82. PubMed ID: 22906841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis.
    Luk BT; Zhang L
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):21859-73. PubMed ID: 25014486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
    Fernandez-Fernandez A; Manchanda R; McGoron AJ
    Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1628-51. PubMed ID: 21947761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-based tumor theranostics with molecular imaging.
    Wang L; Wang Y; Li Z
    Curr Pharm Biotechnol; 2013; 14(7):683-92. PubMed ID: 24372235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of nanoparticles for diagnosis and therapy of cancer.
    Baetke SC; Lammers T; Kiessling F
    Br J Radiol; 2015 Oct; 88(1054):20150207. PubMed ID: 25969868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology.
    Baiu DC; Brazel CS; Bao Y; Otto M
    Curr Pharm Des; 2013; 19(37):6606-21. PubMed ID: 23621531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials.
    Agnihotri TG; Gomte SS; Jain A
    Drug Dev Ind Pharm; 2022 Nov; 48(11):585-601. PubMed ID: 36448770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
    Cabral RM; Baptista PV
    Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and applications of photo-triggered theranostic agents.
    Rai P; Mallidi S; Zheng X; Rahmanzadeh R; Mir Y; Elrington S; Khurshid A; Hasan T
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1094-124. PubMed ID: 20858520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic nanoparticles for cancer and cardiovascular applications.
    Wang D; Lin B; Ai H
    Pharm Res; 2014 Jun; 31(6):1390-406. PubMed ID: 24595494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.